From: TES functions as a Mena-dependent tumor suppressor in gastric cancer carcinogenesis and metastasis
Characteristic | Total (cases) | Mena expression (cases) | χ2 | P value | |
---|---|---|---|---|---|
High | Low | ||||
All | 172 | 99 | 73 | ||
Age (years) | 0.401 | 0.527 | |||
< 55 | 80 | 44 | 36 | ||
≥ 55 | 92 | 55 | 37 | ||
Gender | 0.351 | 0.553 | |||
Male | 115 | 68 | 47 | ||
Female | 57 | 31 | 26 | ||
Tumor infiltration | 13.786 | 0.008 | |||
T1 | 27 | 10 | 17 | ||
T2 | 24 | 9 | 15 | ||
T3 | 3 | 1 | 2 | ||
T4a | 82 | 56 | 26 | ||
T4b | 36 | 23 | 13 | ||
Local lymph node metastasis | 5.115 | 0.024 | |||
N0 | 59 | 27 | 32 | ||
N1–N3 | 113 | 72 | 41 | ||
Distant metastasis | 0.061 | 0.806 | |||
M0 | 152 | 88 | 64 | ||
M1 | 20 | 11 | 9 | ||
TNM stage | 16.565 | 0.001 | |||
0–I | 30 | 9 | 21 | ||
II | 69 | 40 | 29 | ||
III | 50 | 38 | 12 | ||
IV | 23 | 12 | 11 |